Pathology: Page 62

Univ. of Ala. researchers find new head/neck cancer strategy
By DrBicuspid.com staff writers
Combining the drug cetuximab with poly ADP-ribose polymerase inhibitors may improve outcomes in head and neck cancer patients by preventing the cancer cells from repairing damage to DNA as they grow, according to a study in PLoS One.
September 25, 2011
NCI grant to fund head/neck cancer drug study
By DrBicuspid.com staff writers
Researchers from Louisiana State University, the University of Chicago, and 13 other research institutions have been awarded a $1.24 million National Cancer Institute (NCI) grant to evaluate an immunosuppressant drug's potential to prevent the recurrence of head and neck cancer.
September 25, 2011
SWIFT MRI aids oral cancer diagnostics
By DrBicuspid.com staff writers
A preliminary study suggests that a magnetic resonance imaging (MRI) technique called SWIFT (sweep imaging with Fourier transform) can provide a 3Dl assessment that may aid in detecting involvement of the mandible by oral cancer, according to a report in the Archives of Otolaryngology -- Head and Neck Surgery.
September 19, 2011
What accounts for racial differences in head/neck cancer?
By DrBicuspid.com staff writers
Why are African-Americans more likely than Caucasians not only to be diagnosed with head and neck cancer, but also to die from the disease? While the answer isn't a simple one, differences in lifestyle, access to care, and tumor genetics may be partly to blame, according to a new study from Henry Ford Hospital.
September 15, 2011
Study helps ID HPV trends in laryngeal cancer patients
By DrBicuspid.com staff writers
The human papillomavirus (HPV) is more likely to be found in tumors of laryngeal cancer patients who are male and those with private health insurance, according to a new study from researchers at Henry Ford Hospital.
September 14, 2011
Study IDs 23 microRNAs linked to laryngeal cancer
By DrBicuspid.com staff writers
A Henry Ford Hospital study has identified 23 microRNAs for laryngeal cancer, a discovery that could yield new insight into what causes certain cells to grow and become cancerous tumors in the voice box.
September 13, 2011
More research shows spice inhibits head/neck cancer
By DrBicuspid.com staff writers
Curcumin, the main component in the spice turmeric, suppresses a cell signaling pathway that drives the growth of head and neck cancer, according to a new pilot study using human saliva.
September 12, 2011
Nanotechnology targets head/neck cancer
By DrBicuspid.com staff writers
Preclinical studies have shown that the NanoSmart drug-delivery system from Aura Biosciences can enable earlier detection of head and neck and other cancers, and provide precisely targeted treatment of those cancers, according to the company.
September 8, 2011
CDA explores xerostomia in Sept. journal
By DrBicuspid.com staff writers
The September issue of the Journal of the California Dental Association takes an in-depth look at xerostomia (dry mouth), from preventive measures and management to the complications associated with head and neck cancer therapy.
September 7, 2011
General dentists, specialists often misdiagnose oral lesions
By Donna Domino
Endodontists and periodontists were slightly more accurate than general practitioners and oral and maxillofacial surgeons in evaluating suspicious oral lesions, according to a study in Quintessence International. But the error rates were high enough across all groups that the researchers believe all excised lesions should be microscopically analyzed.
September 7, 2011
2010 06 21 15 17 35 214 Question Mark 70
ViziLite helps dental practitioners see leukoplakias
By DrBicuspid.com staff writers
Chemical luminescence can aid in the visualization of oral leukoplakias, according to a study in the Journal of Oral Pathology and Medicine.
September 5, 2011
Medicated patch shows promise in oral cancer prevention
By DrBicuspid.com staff writers
Researchers at the Ohio State University and the University of Michigan have developed a medicated oral patch that allows a chemoprevention drug to release directly into precancerous lesions in the mouth over an extended time.
September 1, 2011
Previous Page
Page 62 of 87
Next Page